Company / Total Debt
C4 Therapeutics, Inc. Total Debt History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
-
FY2023
5-year range
$0 / $11.5M
FY2022-FY2023
Trend
-100.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, total debt decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $11.5M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026